×
About 188,568 results

ALLMedicine™ Prostate Cancer Center

Research & Reviews  86,673 results

Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic H...
https://doi.org/10.1016/j.euf.2021.04.003
European Urology Focus; Wenzel M, Würnschimmel C et. al.

Apr 15th, 2021 - Novel prospective randomized controlled observations addressing combination therapy in metastatic hormone-sensitive prostate cancer (mHSPC) have demonstrated promising overall survival (OS) outcomes. To compare these novel findings and systematica...

Improved Cancer Coping from a Web-based Intervention for Prostate Cancer Survivors: A R...
https://doi.org/10.1002/pon.5701
Psycho-oncology Tagai EK, Miller SM et. al.

Apr 15th, 2021 - Prostate cancer (PCa) survivors report poor physical functioning alongside negative psychological outcomes as they cope with treatment side effects and practical concerns after treatment completion. This study evaluated PROGRESS, a web-based inter...

Dosimetric and clinical outcomes of SpaceOAR in men undergoing external beam radiation ...
https://doi.org/10.1111/1754-9485.13179
Journal of Medical Imaging and Radiation Oncology; Babar M, Katz A et. al.

Apr 15th, 2021 - SpaceOAR, an absorbable polyethylene glycol hydrogel, increases the space between the prostate and rectum to reduce the radiation received by the rectum during prostate cancer radiation therapy. The objective of this systematic review was to evalu...

Male sexual dysfunction and rehabilitation strategies in the settings of salvage prosta...
https://doi.org/10.1038/s41443-021-00437-4 10.1002/pon.4888 10.1007/s00345-019-02749-z 10.1097/JU.0000000000000295 10.1016/j.eururo.2016.08.002 10.1007/s00345-012-0928-8 10.1007/s10552-019-01159-1 10.1111/j.1743-6109.2012.03005.x 10.1016/j.jad.2003.12.008 10.1016/j.eururo.2012.04.047 10.1111/j.1743-6109.2009.01620.x 10.21037/tau.2016.08.12 10.1002/cncr.30263 10.1046/j.1464-410X.2002.02806.x 10.1126/science.1168175 10.1001/jama.294.2.238 10.1080/23809000.2017.1403851 10.1111/bju.14976 10.18632/oncotarget.21519 10.1038/aja.2011.106 10.1007/s00345-013-1029-z 10.1111/bju.12595 10.1016/j.eururo.2012.01.022 10.1016/j.jsxm.2017.08.005 10.1016/j.ijrobp.2014.12.025 10.1038/ijir.2013.28 10.1016/j.ijrobp.2009.04.094 10.1111/jsm.12215 10.5694/mja13.11028 10.1111/j.1464-410X.2011.10800.x 10.1186/s13014-015-0488-3 10.1007/s00345-016-1811-9 10.1111/bju.12151 10.1111/bju.12545 10.1590/s1677-5538.ibju.2017.0025 10.1111/j.1464-410X.2007.07045.x 10.1111/j.1743-6109.2010.01782.x 10.1111/j.1464-410X.2004.05009.x 10.1016/0360-3016(95)00542-7 10.1016/S0360-3016(01)02727-4 10.1016/j.sxmr.2017.09.003 10.1111/jsm.12403 10.1038/ijir.2011.8 10.1016/S0090-4295(02)02397-X 10.1016/j.sxmr.2016.06.005 10.1093/annonc/mdv185 10.1002/pon.3726 10.1007/s00520-019-05215-z 10.1177/1090198105276223 10.1038/ijir.2008.33 10.1016/j.eururo.2008.06.083 10.1016/j.eururo.2013.09.051 10.1111/iju.13202 10.3390/ijms18081794 10.1016/j.jsxm.2019.12.024
International Journal of Impotence Research; Chung E

Apr 15th, 2021 - Male sexual dysfunction, a common sequela following primary prostate cancer (PC) treatment, is likely to be more significant following salvage PC therapy. In general, these impairments in sexual domains can be divided into three groups, namely (1)...

Targeting KDM1B-dependent miR-215-AR-AGR2-axis promotes sensitivity to enzalutamide-res...
https://doi.org/10.1038/s41417-021-00332-6 10.1016/S0140-6736(08)60729-1 10.1038/ncponc0168 10.1016/S0022-5347(02)80307-X 10.1186/s13045-015-0225-2 10.1038/nature13229 10.1158/1078-0432.CCR-11-0728 10.1200/JCO.2010.31.2405 10.3389/fonc.2018.00180 10.1016/j.cell.2004.12.012 10.1038/nature08315 10.1016/j.ccell.2015.12.005 10.1007/s10549-014-3012-9 10.1016/j.prp.2019.02.014 10.1016/j.bbrc.2019.03.140 10.1038/nature04020 10.1530/JME-14-0203 10.1002/gcc.20188 10.1038/s41598-017-15757-z 10.1093/carcin/bgs141 10.1002/pros.22569 10.18632/oncotarget.26342 10.1038/sj.pcan.4500960 10.1186/s12943-019-1115-y 10.1186/s13148-016-0201-x 10.1073/pnas.1802415115 10.1158/1541-7786.MCR-19-0889 10.4081/pr.2020.8495 10.1158/0008-5472.CAN-20-0233 10.1038/nrclinonc.2016.181 10.1016/j.molcel.2012.11.019 10.1093/nar/gkt106 10.1111/febs.12118 10.1016/j.cell.2015.05.001 10.1038/nrc4016 10.1038/s41467-018-07178-x 10.1021/ja101557k 10.1021/bi0618621 10.1002/path.5495 10.1093/carcin/bgy131 10.3858/emm.2011.43.2.011 10.1016/j.ccell.2019.01.008 10.1021/acs.chemrev.6b00801 10.1186/s13148-016-0223-4 10.1016/j.chembiol.2006.05.004 10.1158/1078-0432.CCR-13-3296 10.1158/0008-5472.CAN-14-3080
Cancer Gene Therapy; Tang D, He J et. al.

Apr 15th, 2021 - Post-translational modifications of histones by histone demethylases plays an important role in the regulation of gene transcription and are implicated in cancers. Castrate resistant prostate cancer (CRPC) is often driven by constitutively active ...

see more →

Guidelines  393 results

ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but...
https://doi.org/10.1016/j.prro.2020.10.002
Practical Radiation Oncology; Zietman AL,

Dec 14th, 2020 - ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but Changing Role for the Radiation Oncologist.|2020|Zietman AL, ,|

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.
https://doi.org/10.1097/JU.0000000000001376
The Journal of Urology; Lowrance WT, Breau RH et. al.

Sep 22nd, 2020 - The summary presented herein represents Part II of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients with castration-resistant disease. Please refer ...

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.
https://doi.org/10.1097/JU.0000000000001375
The Journal of Urology; Lowrance WT, Breau RH et. al.

Sep 22nd, 2020 - The summary presented herein represents Part I of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients with biochemical recurrence without metastatic di...

American Society for Radiation Oncology Editorial: Rapidly Evolving Technologies Relate...
https://doi.org/10.1016/j.prro.2020.06.009
Practical Radiation Oncology; Bauman GS, Jani AB

Sep 6th, 2020 - American Society for Radiation Oncology Editorial: Rapidly Evolving Technologies Related to Imaging Strategies for Advanced Prostate Cancer.|2020|Bauman GS,Jani AB,|

Optimizing the management of castration-resistant prostate cancer patients: A practical...
https://doi.org/10.1002/pros.24053
The Prostate REFERENCES; Shore ND, Drake CG et. al.

Aug 11th, 2020 - Advanced prostate cancer (PC) patients, especially those with metastatic prostate cancer (mPC), often require complex management pathways. Despite the publication of clinical practice guidelines by leading urological and oncological organizations ...

see more →

Drugs  339 results see all →

Clinicaltrials.gov  94,441 results

Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic H...
https://doi.org/10.1016/j.euf.2021.04.003
European Urology Focus; Wenzel M, Würnschimmel C et. al.

Apr 15th, 2021 - Novel prospective randomized controlled observations addressing combination therapy in metastatic hormone-sensitive prostate cancer (mHSPC) have demonstrated promising overall survival (OS) outcomes. To compare these novel findings and systematica...

Improved Cancer Coping from a Web-based Intervention for Prostate Cancer Survivors: A R...
https://doi.org/10.1002/pon.5701
Psycho-oncology Tagai EK, Miller SM et. al.

Apr 15th, 2021 - Prostate cancer (PCa) survivors report poor physical functioning alongside negative psychological outcomes as they cope with treatment side effects and practical concerns after treatment completion. This study evaluated PROGRESS, a web-based inter...

Dosimetric and clinical outcomes of SpaceOAR in men undergoing external beam radiation ...
https://doi.org/10.1111/1754-9485.13179
Journal of Medical Imaging and Radiation Oncology; Babar M, Katz A et. al.

Apr 15th, 2021 - SpaceOAR, an absorbable polyethylene glycol hydrogel, increases the space between the prostate and rectum to reduce the radiation received by the rectum during prostate cancer radiation therapy. The objective of this systematic review was to evalu...

Male sexual dysfunction and rehabilitation strategies in the settings of salvage prosta...
https://doi.org/10.1038/s41443-021-00437-4 10.1002/pon.4888 10.1007/s00345-019-02749-z 10.1097/JU.0000000000000295 10.1016/j.eururo.2016.08.002 10.1007/s00345-012-0928-8 10.1007/s10552-019-01159-1 10.1111/j.1743-6109.2012.03005.x 10.1016/j.jad.2003.12.008 10.1016/j.eururo.2012.04.047 10.1111/j.1743-6109.2009.01620.x 10.21037/tau.2016.08.12 10.1002/cncr.30263 10.1046/j.1464-410X.2002.02806.x 10.1126/science.1168175 10.1001/jama.294.2.238 10.1080/23809000.2017.1403851 10.1111/bju.14976 10.18632/oncotarget.21519 10.1038/aja.2011.106 10.1007/s00345-013-1029-z 10.1111/bju.12595 10.1016/j.eururo.2012.01.022 10.1016/j.jsxm.2017.08.005 10.1016/j.ijrobp.2014.12.025 10.1038/ijir.2013.28 10.1016/j.ijrobp.2009.04.094 10.1111/jsm.12215 10.5694/mja13.11028 10.1111/j.1464-410X.2011.10800.x 10.1186/s13014-015-0488-3 10.1007/s00345-016-1811-9 10.1111/bju.12151 10.1111/bju.12545 10.1590/s1677-5538.ibju.2017.0025 10.1111/j.1464-410X.2007.07045.x 10.1111/j.1743-6109.2010.01782.x 10.1111/j.1464-410X.2004.05009.x 10.1016/0360-3016(95)00542-7 10.1016/S0360-3016(01)02727-4 10.1016/j.sxmr.2017.09.003 10.1111/jsm.12403 10.1038/ijir.2011.8 10.1016/S0090-4295(02)02397-X 10.1016/j.sxmr.2016.06.005 10.1093/annonc/mdv185 10.1002/pon.3726 10.1007/s00520-019-05215-z 10.1177/1090198105276223 10.1038/ijir.2008.33 10.1016/j.eururo.2008.06.083 10.1016/j.eururo.2013.09.051 10.1111/iju.13202 10.3390/ijms18081794 10.1016/j.jsxm.2019.12.024
International Journal of Impotence Research; Chung E

Apr 15th, 2021 - Male sexual dysfunction, a common sequela following primary prostate cancer (PC) treatment, is likely to be more significant following salvage PC therapy. In general, these impairments in sexual domains can be divided into three groups, namely (1)...

Targeting KDM1B-dependent miR-215-AR-AGR2-axis promotes sensitivity to enzalutamide-res...
https://doi.org/10.1038/s41417-021-00332-6 10.1016/S0140-6736(08)60729-1 10.1038/ncponc0168 10.1016/S0022-5347(02)80307-X 10.1186/s13045-015-0225-2 10.1038/nature13229 10.1158/1078-0432.CCR-11-0728 10.1200/JCO.2010.31.2405 10.3389/fonc.2018.00180 10.1016/j.cell.2004.12.012 10.1038/nature08315 10.1016/j.ccell.2015.12.005 10.1007/s10549-014-3012-9 10.1016/j.prp.2019.02.014 10.1016/j.bbrc.2019.03.140 10.1038/nature04020 10.1530/JME-14-0203 10.1002/gcc.20188 10.1038/s41598-017-15757-z 10.1093/carcin/bgs141 10.1002/pros.22569 10.18632/oncotarget.26342 10.1038/sj.pcan.4500960 10.1186/s12943-019-1115-y 10.1186/s13148-016-0201-x 10.1073/pnas.1802415115 10.1158/1541-7786.MCR-19-0889 10.4081/pr.2020.8495 10.1158/0008-5472.CAN-20-0233 10.1038/nrclinonc.2016.181 10.1016/j.molcel.2012.11.019 10.1093/nar/gkt106 10.1111/febs.12118 10.1016/j.cell.2015.05.001 10.1038/nrc4016 10.1038/s41467-018-07178-x 10.1021/ja101557k 10.1021/bi0618621 10.1002/path.5495 10.1093/carcin/bgy131 10.3858/emm.2011.43.2.011 10.1016/j.ccell.2019.01.008 10.1021/acs.chemrev.6b00801 10.1186/s13148-016-0223-4 10.1016/j.chembiol.2006.05.004 10.1158/1078-0432.CCR-13-3296 10.1158/0008-5472.CAN-14-3080
Cancer Gene Therapy; Tang D, He J et. al.

Apr 15th, 2021 - Post-translational modifications of histones by histone demethylases plays an important role in the regulation of gene transcription and are implicated in cancers. Castrate resistant prostate cancer (CRPC) is often driven by constitutively active ...

see more →

News  6,555 results

Healthy Lifestyle May Offset Genetic Risk in Prostate Cancer
https://www.medscape.com/viewarticle/949334

Apr 14th, 2021 - Adhering to a healthy lifestyle may offset the heightened risk of lethal prostate cancer in patients with adverse genetic risk factors, according to results of a large U.S. study. In men at the highest risk of dying from prostate cancer, having th...

Rankings of Most Common Cancers to Shift Over Next 20 Years
https://www.medscape.com/viewarticle/949253

Apr 13th, 2021 - The next 20 years will see a big shift in cancer type rankings, researchers predict. At the moment, the most common cancers in the United States are breast, lung, prostate, colorectal, and melanoma. By 2040, melanoma will have become the second mo...

Novel Genomic Alterations in Circulating Tumor Cells Tied to Castrate-Resistant Prostate Cancer
https://www.medscape.com/viewarticle/949075

Apr 11th, 2021 - NEW YORK (Reuters Health) - Novel genomic alterations in circulating tumor cells (CTCs) - beyond the androgen receptor (AR)-V7 splice variant - are associated with outcomes and resistance to hormone therapy in metastatic castrate-resistant prostat...

Doctor Denies Profits Drove HIFU Cancer Referrals 
https://www.medscape.com/viewarticle/949043

Apr 8th, 2021 - A doctor denied wanting to make money when he referred eight cancer patients for treatment on a machine he co-owned, a medical tribunal has heard. Consultant urologist Paul Miller, 63, was said to have had only the "best clinical interests" of his...

Targeting Glutamine Could Curb Castration-Resistant Prostate Cancer
https://www.medscape.com/viewarticle/948322

Mar 29th, 2021 - NEW YORK (Reuters Health) - Targeting glutamine, rather than the androgen receptor (AR), successfully inhibited tumor growth in experiments in prostate cancer cells, tissue and animal models, potentially paving the way to clinical trials, research...

see more →

Patient Education  167 results see all →